Back
State Street SPDR S&P Dividend ETF Vs. BioMarin Pharmaceutical, Inc. Industry Stock Comparison
Buy
64
SDY
State Street SPDR S&P Dividend ETF
Last Price:
$140.36
Seasonality Move:
-0.68%
Buy
54
BMRN
BioMarin Pharmaceutical, Inc.
Last Price:
$61.19
Seasonality Move:
5.52%
Buy
64
State Street SPDR S&P Dividend ETF (SDY)
is a Buy
Is State Street SPDR S&P Dividend ETF a Buy, Sell or Hold?
-
The current State Street SPDR S&P Dividend ETF [SDY] share price is $140.33. The Score for SDY is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
SDY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
BioMarin Pharmaceutical, Inc. (BMRN)
is a Buy
Is BioMarin Pharmaceutical, Inc. a Buy, Sell or Hold?
-
The current BioMarin Pharmaceutical, Inc. [BMRN] share price is $61.15. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SDY Stock Price Chart
What is State Street SPDR S&P Dividend ETF's stock price today?
-
The State Street SPDR S&P Dividend ETF share price today is $140.33Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SDY is experiencing selling pressure, which indicates risk of future bearish movement.
BMRN Stock Price Chart
What is BioMarin Pharmaceutical, Inc.'s stock price today?
-
The BioMarin Pharmaceutical, Inc. share price today is $61.15Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMRN is experiencing slight buying pressure.
SDY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 26.47 | Buy |
| Relative Strength Index (14 RSI): | 52.76 | Buy |
| Chaikin Money Flow: | -239153 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (137.83 - 141.09) | Buy |
| Bollinger Bands (100): | (137.81 - 140.91) | Buy |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 73.39 | Buy |
| Chaikin Money Flow: | 7836963 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.19 - 56.01) | Buy |
| Bollinger Bands (100): | (52.65 - 57.43) | Buy |
SDY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 141.07 | Sell |
| 20-day SMA: | 140.07 | Buy |
| 50-day SMA: | 138.89 | Buy |
| 200-day SMA: | 136.84 | Buy |
| 8-day EMA: | 74.57 | Buy |
| 20-day EMA: | 36.54 | Buy |
| 50-day EMA: | 15.93 | Buy |
| 200-day EMA: | 4.16 | Buy |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.6 | Buy |
| 20-day SMA: | 54.21 | Buy |
| 50-day SMA: | 53.61 | Buy |
| 200-day SMA: | 57.94 | Buy |
| 8-day EMA: | 54.44 | Buy |
| 20-day EMA: | 53.99 | Buy |
| 50-day EMA: | 54.1 | Buy |
| 200-day EMA: | 58.28 | Buy |
State Street SPDR S&P Dividend ETF Earnings Growth & SDY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
BioMarin Pharmaceutical, Inc. Earnings Growth & BMRN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.97 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $1.68 per share.
State Street SPDR S&P Dividend ETF Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BioMarin Pharmaceutical, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||